Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD) - Takeaways - MDSpire

Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD)

  • By

  • Ye Li

  • Xiangyu Fu

  • Ling Huang

  • Lirong Xiao

  • Danian Chen

  • April 24, 2026

  • 0 min

Share

  • 1

    Type 3 macular neovascularization (MNV3) is a significant cause of vision loss in age-related macular degeneration (AMD), with increasing incidence detected by optical coherence tomography.

  • 2

    A total of 564 publications on MNV3 were analyzed, revealing the United States as the leading contributor to research in this area.

  • 3

    Key research topics in MNV3 include pathogenesis, imaging, therapy, and clinical prognosis, with emerging interests in artificial intelligence and biomarkers.

  • 4

    Ranibizumab and photodynamic therapy are prominent treatment keywords, while anti-VEGF therapy remains the first-line treatment despite its limitations.

  • 5

    The bibliometric analysis provides insights into the evolving research landscape of MNV3, highlighting collaboration networks and future research directions.

Original Source(s)

Related Content